Detalhe da pesquisa
1.
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
Clin Genitourin Cancer
; : 102052, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461085
2.
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic.
Immunotherapy
; 15(12): 921-932, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37431608
3.
A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic.
Cancer Treat Res Commun
; 34: 100678, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608489
4.
No association between BMI and immunotoxicity or clinical outcomes for immune checkpoint inhibitors.
Immunotherapy
; 14(10): 765-776, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695057
5.
Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors.
Immunotherapy
; 14(1): 23-30, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758641
6.
Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases.
J Immunother
; 44(9): 362-370, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121061